コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 etween gene transcript levels and HLA ligand presentation.
2 characterized by a highly variable clinical presentation.
3 virus was detected in the CSF at the time of presentation.
4 n activity during the unimodal A (but not V) presentation.
5 at the time of the patient's initial disease presentation.
6 ns to target antigens with ultra-low surface presentation.
7 circulating biomarkers measured at hospital presentation.
8 tion, enriched for IFN signaling and antigen presentation.
9 nting with acute cSAH and 97 without cSAH at presentation.
10 e they usually require amphetamine for their presentation.
11 gens in the context of CD1d-mediated antigen presentation.
12 rum of this gene and the associated clinical presentation.
13 (SNAP and DETA-NONOate) inhibited DC antigen presentation.
14 yndrome, which shows disparities in clinical presentation.
15 c and nonhemorrhagic groups based on initial presentation.
16 possible' bvFTD diagnostic criteria at first presentation.
17 nd standard-sensitivity cTn were measured at presentation.
18 ng various organs and has a diverse clinical presentation.
19 in females compared to males during stimulus presentation.
20 igrating have been activated towards antigen presentation.
21 , if modified in people, might alter disease presentation.
22 impairment in fear memory extinction to tone presentation.
23 CC patients were categorized by MC status at presentation.
24 ents with a m.3243 A > G negative MELAS-like presentation.
25 ticulum-phagosome traffic required for cross-presentation.
26 was already present in 62 patients at first presentation.
27 disease, but substantially modifies disease presentation.
28 eurosurgical patients during visual stimulus presentation.
29 lly learning the rules of endogenous antigen presentation.
30 nterferons and hence enhances tumour antigen presentation.
31 ure that subjects have control over stimulus presentation.
32 lecule H2-O, a negative regulator of antigen presentation.
33 anage repeat patients or more complicated TB presentations.
34 cobacteria and have autoinflammatory disease presentations.
35 to minimally symptomatic or non-symptomatic presentations.
36 A interference (RNAi) in both early and late presentations.
37 fluence of contrast was strongest with brief presentations.
38 characteristic clinical and histopathologic presentations.
49 CI 1.11-1.38) in children with diarrhoea at presentation and 1.76 (1.47-2.11) in children without di
50 sepsis and septic shock patients at initial presentation and 2) determine the association between ti
51 a combination of both time-dependent antigen presentation and a novel mechanism through which IL-12 a
53 impaired fetal growth, preterm birth, breech presentation and cesarean section were associated with a
54 Substantial overlap exists in the clinical presentation and comorbidities among patients with Middl
55 ecretory granules for antigen processing and presentation and creating a feed-forward loop of T-cell-
57 ignificantly enhanced antigen-specific cross-presentation and cytotoxic T lymphocyte (CTL) activity.
59 ade by the combination of a typical clinical presentation and evidence of nut specifc IgE shown by a
60 ed to the individual patient on the basis of presentation and hemodynamic conditions may be beneficia
61 enging due to the highly variable phenotypic presentation and limited correlation has been identified
63 lement activation, can modulate both antigen presentation and T cell priming, ultimately leading to a
65 We show that MCs adapt to continuous odor presentation and that mixture responses are different wh
66 osition, which has an impact on the clinical presentation and the underlying disease that triggers cr
67 the consecutive NAION event based on initial presentation and to compare mean visual loss of firstly
69 44, 69] vs 70 [52, 78]; p < 0.001), clinical presentations and comorbidities overlapped substantially
70 r integrating themes emerged across workshop presentations and discussion and centered on 1) physiolo
77 R) Country Operational Plans, and conference presentations and/or abstracts for the latest available
78 edian of 4.4 years, many from first clinical presentation, and 106 scans of 80 healthy paediatric par
79 iation dose, bilateral ocular involvement at presentation, and advanced stage were significantly corr
82 the molecular basis that governs the antigen presentation, and the interactions between antigens and
83 Hazard rates of AT across lifetime, age at presentation, and the time lapse between surgery and the
84 s suggesting that other mechanism of antigen presentation are driving the robust T cell response obse
85 utive caspase-1 activation, their phenotypic presentations are different, implying that these mutatio
87 a cardiac troponin I threshold of 5 ng/L at presentation as a risk stratification tool in patients w
89 revealed a hierarchical pattern of spot sign presentations, as follows: A > B > C > D > no spot sign
92 ho underwent appendectomy within 24 hours of presentation at 23 children's hospitals from January 1,
94 17/221 promoted beta1 integrin recycling and presentation back onto the surface of macrophages, in pa
96 findings in the context of patient clinical presentations because accurate interpretation of pathoge
98 e that M. tuberculosis EsxL inhibits antigen presentation by enhancing H3K9me2/3 at the CIITA promote
101 first described as processors of antigen for presentation by major histocompatibility complex molecul
103 change in voice, and dry skin, but clinical presentation can differ with age and sex, among other fa
104 The ability to recognize these variable presentations can be important for the diagnosis of TSC.
107 FN-gamma-responsive genes related to antigen presentation, chemokine expression, cytotoxic activity,
108 pathways including those involved in antigen presentation, chemotaxis, innate and adaptive immunity a
109 ility of S. aureus, heterogeneity of disease presentation, clinical course, and outcome between indiv
110 e shorter delays from symptom development to presentation compared with women who had never undergone
111 h adenovirus, a model for intrahepatic cross-presentation, confirms hepatocytes directly contribute t
112 our data reveal a mechanism by which antigen presentation controls the innate effector function of Th
113 re the first record of 1 of 4 cardiovascular presentations (coronary heart disease [CHD], cerebrovasc
114 were divided into 2 groups based on date of presentation: decade 1 (1995-2005) and decade 2 (2006-20
115 retinitis involving >/=25% of the retina at presentation detached at nearly 12 times the rate, as co
117 ch as pathophysiology, patient demographics, presentation, diagnosis, treatment, and outcomes, were e
118 eal fetus in fetu and discusses its clinical presentation, differential diagnosis and embryologic ori
119 nown, and it is unclear whether the clinical presentation differs between patients positive for PLA2R
120 ved TAMs played more potent roles in antigen presentation, embryonically derived TAMs exhibited a pro
122 nalyze Sec61's contribution to antigen cross-presentation, ERAD, and transport of internalized antige
123 This review will give an overview of the presentation, evaluation, and treatment of immunocompete
124 DCs from these mice show impaired cross-presentation ex vivo and defective cross-priming of CD8(
126 pporting an impaired endocytic lipid antigen presentation for T cell activation upon benzo[a]pyrene e
127 hospital resource use and care costs for all presentations for self-harm to the John Radcliffe Hospit
129 ial Results, CardioSource, and abstracts and presentations from major cardiovascular meetings up to A
130 bMed and Embase and conference abstracts and presentations from the Conference on Retroviruses and Op
131 tem in ALS may translate into the split hand presentation, gait disturbance, split leg syndrome and b
133 was associated with upregulation of antigen presentation genes, which correlated (r=0.78) with T-cel
135 Myocarditis was diagnosed based on clinical presentation, high-sensitivity troponin T, and cardiac m
140 dy demonstrates a mechanism regulating cross-presentation in cancer and suggests potential therapeuti
141 We conclude that Sec22b-dependent cross-presentation in DCs is required to initiate CD8(+) T cel
142 using death, place of death, time from index presentation in last year of life to death, whether enro
145 nse by efficiently stimulating antigen cross-presentation in vivo and in vitro assessed by BMDC OT-I
147 till learning more about the myriad clinical presentations in these severely affected children, it is
148 n essential component of MHC class I antigen presentation, in 29.4% of patients with progressing dise
149 HspQ via a C-terminal degron, whose precise presentation, in synergy with multipartite contacts with
151 owed that expression of mediators of antigen presentation, including MHC class I and beta2 microglobu
152 n of genes related to antigen processing and presentation, including the gene encoding the major hist
153 bilities with three main phenotypic clinical presentations, including logopenic, non-fluent/agrammati
154 CI: 1.07, 1.92; p = 0.016), with respiratory presentations increasing by 52% with fortified SQ-LNS (a
155 ve been associated with overlapping clinical presentations, indicating shared and distinct functions
160 most significantly associated with clinical presentation: intrarenal polyomavirus load levels and Ba
161 -corrected visual acuity (BCVA) was 20/30 at presentation (IQR, 0.00-0.50) and remained at 20/30 thro
167 a consortium aiming to describe the clinical presentation, management, and outcomes of patients with
168 an action, and yoked extinction, with shock presentation matched to the active condition, but withou
169 with the same disease and a similar clinical presentation may have very different outcomes and need v
170 last examination, 64.41 +/- 6.76 months from presentation, mean final VA was 20/283 (logMAR equivalen
173 cytokine module that, along with the antigen presentation module, promoted the generation of effector
176 linical, and echocardiographic data at first presentation of 1992 patients with BAV (71.5% men) were
178 clinical phenotype ranges from the classical presentation of a congenital myasthenic syndrome in one
179 ose-derived stem cells (hASCs), allowing the presentation of a continuous range of stiffnesses in a s
180 ensity EEG, we show that, already before the presentation of a critical word, context-induced semanti
181 sker response amplitude is also modulated by presentation of a movie recreating the mouse's visual ex
184 a that shows increased c-Fos expression upon presentation of a sour tastant (30 mM citric acid).
185 These findings are relevant to the clinical presentation of acetaminophen-hepatotoxicity and may inf
186 ow Ragulator functions as a platform for the presentation of active Rags for mTORC1 recruitment, and
187 nventional retinotopic mapping with episodic presentation of adjacent stimuli, a continuous, periodic
188 a cancer diagnosis, understand the clinical presentation of adult patients with cancer in the ED, an
189 rms hepatocytes directly contribute to cross-presentation of Ags and priming the pool of naive CD8(+)
190 an trace conditioning procedure in which the presentation of an auditory cue and food were separated
191 al autophagy, key processes that control the presentation of antigens by dendritic cells (DCs) to nai
192 y, consistent with their defect in the cross-presentation of apoptotic cells, DC-specific Vps34-defic
193 aper, we aimed to report an atypical imaging presentation of CPAM type II in the second trimester, ex
194 two complementary theories that explain the presentation of disease symptoms on the basis of changes
195 a combination of factors, including earlier presentation of disease, fewer eyes being observed witho
196 tructive to productive and facilitates cross-presentation of disease-relevant epitopes to CD8(+) T ce
197 ven when the non-rest condition includes the presentation of emotional provoking stimuli, particularl
198 od, patient age and multi-morbidity at first presentation of heart failure increased (mean age 76.5 y
200 e and evolution of clinical and pathological presentation of HIV-associated neurocognitive disorders
201 transcription factor Foxp3 in T cells, trans-presentation of IL-6 by DC-bound IL-6Ralpha (called 'IL-
202 present study we investigated Ag uptake and presentation of in vivo-formed Ag-Ab complexes by i.v. i
203 in clinical practice as well as the diverse presentation of intestinal melanoma metastases and the d
205 by trypanosomes and are associated with the presentation of neurological disturbances independently
206 nfirmation of previously described genes and presentation of novel candidates and provide an overview
208 luding breast cancer, which results in cross-presentation of PR1, an NE-derived HLA-A2-restricted pep
209 sion injury also promoted DC-dependent cross-presentation of renal antigens to CD8 T cells in the dra
210 racranial recordings and visual word-by-word presentation of sentences and word lists to investigate
211 utations of pattern separation to subsequent presentation of similar stimuli.SIGNIFICANCE STATEMENT T
213 s other than breast cancer prior to clinical presentation of that cancer, for ductal carcinoma in sit
215 emical inhibition of Usp14 diminished direct presentation of the model antigenic peptide, and the eff
217 al cells (TECs) through their expression and presentation of tissue-specific Ags to developing thymoc
218 nt biological or neural damage, (b) to avoid presentation of uncomfortably loud sounds, and (c) to en
221 ly healthy obese individuals and 4 different presentations of incident cardiovascular disease in a co
223 New research criteria that recognise early presentations of PSP and operationalise diagnosis of the
226 eremia), in patients at the time of clinical presentation on IL-10 production and its association wit
229 the CS and during the ISI, but not during US presentations or in the ITI) after infusion in mPFC, whe
231 F]FEPPA VT and duration of illness, clinical presentation, or neuropsychological measures after adjus
232 tic biomolecules often result in short-lived presentations, or require genetic manipulation to facili
233 onsider duration range, number of trials and presentation order as crucial factors modulating perform
234 Our results constitute the first report of presentation order effects in the Episodic Temporal Gene
236 determine the association of gender with the presentation, outcome, and host response in critically i
237 present across the entire period of patient presentation, particularly in those experiencing a secon
239 ate that functional Usp14 enhances direct Ag presentation, preferentially of DRiP-derived peptides, s
240 l age at birth, birthweight, stage of ROP at presentation, prior treatment (laser or cryotherapy), su
243 ants' performance improved with asynchronous presentation relative to synchronous - temporal ventrilo
246 eloped and applied a residue-centric patient presentation score to 9,176 cancer patients across 1,018
247 of cortical activity before and during tone presentation shows that these changes in evoked and spon
250 contribution of factors critical to epitope presentation, such as protein cleavage and gene expressi
251 atter progressively increased after clinical presentation, suggesting not only a failure of age-expec
252 Genetic cases were significantly younger at presentation than Clinical cases (40.6+/-12.5 vs. 47.5+/
253 n discovered to have impaired vision, with a presentation that resembles syndromes of elevated intrac
254 The more arterial the pattern of spot sign presentation, the greater the frequency of substantial h
255 reward-based effects required long stimulus presentation, the influence of contrast was strongest wi
259 was the odds of discharge within 6 hours of presentation There were 11 529 participants in the preim
260 w report that ImmunoCloak interrupts antigen presentation thereby preventing early T cell activation
262 and 55 (38.2%) visually impaired patients at presentation to 2 (1.4%) and 5 (3.5%) patients respectiv
265 ake a pragmatic comparison of the risk of re-presentation to hospital with vivax malaria in patients
266 nfirmed EVD had similar Ebola viral loads on presentation to nonpregnant women, as measured by initia
269 nation of three standard criteria including: presentation to the emergency department for medical car
271 rent knowledge of the epidemiology, clinical presentation, treatment, and pathogenesis of these tumor
272 urther on to humans, and the severe clinical presentation typical in these latter incidental hosts.
273 of T cells stimulated by IL-2 and by antigen presentation using a Theileria-transformed cell line and
276 Delay of appendectomy within 24 hours of presentation was not associated with increased risk of c
277 sol, suggesting that the inhibition of cross-presentation was not related to either of these traffick
278 A trend toward an increased bleeding rate at presentation was observed in HHT (p = 0.069) and an incr
279 nd the effect was especially pronounced when presentation was restricted to the defective ribosomal p
283 matter (GM) and white matter (WM) atrophy at presentation were assessed and tested as predictors of p
285 he risk stratification threshold (5 ng/L) at presentation were reported for a primary outcome of inde
288 esulted in both higher and prolonged antigen presentation when compared to disulfide-linked peptide.
289 The mean time from surgical procedure to presentation with endophthalmitis was 6.8 months (range:
290 than 23% as a measure of hydration status at presentation with HUS was associated with the developmen
295 CABG over PCI no longer varied by acuity of presentation, with a hazard ratio for MACCE in ACS patie
296 rganisms can be optimized by manipulating Ag presentation, with implications for vaccine design.
297 harbor high-risk histopathologic features at presentation, with the absence of vitreous seeds being a
298 sing of Gag can lead to a 50% probability of presentation within 3 hours post-infection, as observed
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。